Cargando…
EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential
Autores principales: | Li, Yong, Xu-Monette, Zijun Y., Abramson, Jeremy, Sohani, Aliyah R., Bhagat, Govind, Tzankov, Alexandar, Visco, Carlo, Zhang, Shanxiang, Dybkaer, Karen, Pan, Zenggang, Xu, Min, Tam, Wayne, Zu, Youli, Hsi, Eric D., Hagemeister, Fredrick B., Go, Heounjeong, van Krieken, J. Han, Winter, Jane N., Ponzoni, Maurilio, Ferreri, Andrés J. M., Møller, Michael B., Piris, Miguel A., Wang, Yingjun, Zhang, Mingzhi, Young, Ken H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119604/ https://www.ncbi.nlm.nih.gov/pubmed/36399513 http://dx.doi.org/10.1182/bloodadvances.2022008550 |
Ejemplares similares
-
XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53
por: Deng, Manman, et al.
Publicado: (2020) -
Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies
por: Xu-Monette, Zijun Y., et al.
Publicado: (2019) -
Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms
por: Albitar, Maher, et al.
Publicado: (2022) -
Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocations
por: Visco, Carlo, et al.
Publicado: (2017) -
Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma–is it necessary?
por: Ok, Chi Young, et al.
Publicado: (2015)